Launched in 2019, Dewpoint is based on the work of Anthony Hyman, a researcher who was part of the team that discovered biomolecular condensates. Shape-shifting blobs, these condensates form inside cells and can contain proteins and other molecules. Researchers have started to explore how condensates affect chemical reactions in the cell and potentially play a role in disease.
Dewpoint is one of several biotechnology companies attempting to create new treatments through studying condensates. While Dewpoint is working across several different therapeutic areas, its metabolic research is what drew the attention of Novo, the pharma company that sells the in-demand diabetes drug Ozempic.
The partnership will focus on the discovery of small molecule drugs to treat insulin resistance and diabetic complications. The companies claim that undoing the dysregulation of condensates could help forestall development of insulin resistance, which is a key factor in Type 2 diabetes. READ MORE
by Delilah Alvarado
Source: biopharmadive.com
Giovanni Caforio, the former CEO of Bristol Myers Squibb, is set to become the next board chairman of Novartis, which on Tuesday proposed the pharmaceutical industry veteran as its pick to replace Joerg Reinhardt in the role next year. Reinhardt has served as Novartis’ chair since 2013 and plans to retire when his 12-year term ends in 2025.
GE HealthCare has raised the curtain on two ultrasound systems equipped with artificial intelligence programs designed to assist in diagnosing conditions in women’s health, including obstetric exams. The Voluson Signature 20 and 18 imaging systems include AI tools capable of automatically identifying and annotating measurements of fetal anatomy.
Scientists from the University of Edinburgh’s School of Chemistry have revealed a new sustainable method of manufacturing complex molecules that could reduce waste produced during drug production. The method published in Nature Chemistry could help to prevent severe side effects caused by drugs that can exist as enantiomers.
